FDA Approves Wegovy, a High-Dose Version of the Diabetes Drug Semaglutide for Use as Aid to Weight Loss
Wegovy — a high-dose version of the diabetes drug semaglutide — has been approved as a new aid to weight loss by the U.S. Food and Drug Administration. Studies funded by drug maker Novo Nordisk showed that participants who received weekly injections of the drug had an average weight loss of 15% and lost weight… Read More »